Intellia Therapeutics, Inc. (NTLA) has a market capitalization of $1.75B and trades at $14.78. The 52-week range is 5.9-28.25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.9, Earnings Per Share (EPS) of $-3.81, annual revenue of $67.67M.
The stock has a beta of 1.99, operates in the Healthcare sector.
